Business Standard

AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

Related News

India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 

Read more on:   
|
|

Read More

Metal shares rises as LMEX surges 5%

Hindalco Industries, Sterlite Industries, Tata Steel, Sesa Goa, NMDC and Hindustan Zinc are up 2-4% on BSE.

Recommended for you

Advertisements

Quick Links

Market News

Street looks to Britannia for pleasing numbers

Traditionally, the third quarter witnesses higher expenditure in terms of ad spends and promotional events

Reliance MF closed-ended equity fund gets record Rs 1,000 cr

RCAM CEO Sundeep Sikka thanked the investors and said that they are encouraged by this response

Markets trade lower ahead of Jan F&O expiry

Markets remain rangebound in a tight range on caution ahead of Jan F&O expiry

Global strategists say markets pricing a delay in rate hikes in US, UK

Central banks across the world seem to be gearing up to prevent a sharp slowdown born out of economic deflation

Oriental Bank of Commerce slumps on weak Q3 results

The bank has slumped by over 8% at Rs 287 after reporting a 91.27% decline in net profit at Rs 19.56 cr

 

Back to Top